Point d'actu avec Christophe Dombu, analyste Pharma / Biotech chez Portzamparc

from Le Journal des Biotechs · host BOURSORAMA

Dans ce numéro du journal des biotechs, Christophe Dombu, analyste Pharma / Biotech chez Portzamparc revient sur la flambée récente des valeurs biotechs en Bourse et sur celles qui sont en lutte contre le Covid-19Hébergé par Audiomeans. Visitez audiomeans.fr/politique-de-confidentialite pour plus d'informations.

Episode metadata supplied by the publisher feed · Published May 4, 2020

Embed this episode

Attribution link and audio player

NOW PLAYING

Point d'actu avec Christophe Dombu, analyste Pharma / Biotech chez Portzamparc

0:00 16:55

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Le Journal des Biotechs?

This episode is 16 minutes long.

When was this Le Journal des Biotechs episode published?

This episode was published on May 4, 2020.

Can I download this Le Journal des Biotechs episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!